AngioSculpt OTW PTA Scoring Balloon Catheter 2155-3040Recalls & reported problems
The Spectranetics Corporation · Class 2
All models of AngioSculpt OTW PTA Scoring Balloon Catheter (15)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 3
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 00813132021320), received between Sep 19, 2018 and Nov 12, 2020 — classified as 1 injury, 2 malfunctions.
The most frequently reported specific device problem is “Material Rupture” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Material Rupture2
- Detachment of Device or Device Component1
- Entrapment of Device1
- Failure to Advance1
Patient problems
- No Consequences Or Impact To Patient3
Recent adverse event reports
The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.
MalfunctionNov 12, 2020Material Rupture; Material Rupture
THE ANGIOSCULPT DEVICE WAS USED TO TREAT A MODERATELY CALCIFIED AND SLIGHTLY TORTUOUS PROXIMAL ANTERIOR TIBIAL AND POPLITEAL ARTERY. DURING INFLATION AT 5-6 ATM, BLOOD WAS SEEN IN THE ENDOFLATOR INDICATING A BALLOON RUPTURE OR TEAR. A NEW ANGIOSCULPT DEVICE WAS USED TO COMPLETE THE PROCEDURE. NO PATIENT INJURY REPORTED.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 10833505 ↗InjuryFeb 28, 2019Entrapment of Device; Failure to Advance; Entrapment of Device; Failure to Advance
THE ANGIOSCULPT DEVICE GOT STUCK ON THE GUIDE WIRE IN TRANSIT TO THE LESION; THEREFORE, IT WAS REMOVED AS A SYSTEM. THE PHYSICIAN REWIRED THE LESION AND COMPLETED THE PROCEDURE WITH A NEW ANGIOSCULPT DEVICE.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 8377930 ↗MalfunctionSep 19, 2018Material Rupture; Detachment of Device or Device Component; Material Rupture; Detachment of Device or Device Component
THE ANGIOSCULPT DEVICE RUPTURED WHILE BEING INFLATED AT 18 ATM. THE DEVICE WAS REMOVED WITH NO PATIENT INJURY. THE PROCEDURE WAS COMPLETED WITH A CSI AND 4.5 X 120 MM SUPERA STENT, THEN POST DILATED WITH 4 X 40 MM RAPIDCROSS CATHETER. NOTE: RETURNED PRODUCT INVESTIGATION FOUND THE SCORING ELEMENT RINGS DETACHED FROM THE DISTAL BOND.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 7890095 ↗
Other Catheter, Percutaneous, Cutting/Scoring devices
- AngioSculpt OTW PTA Scoring Balloon Catheter 2092-6040The Spectranetics Corporation · Catheter, Percutaneous, Cutting/Scoring41 reports
- AngioSculpt OTW PTA Scoring Balloon Catheter 2076-5040The Spectranetics Corporation · Catheter, Percutaneous, Cutting/Scoring31 reports
- AngioSculpt OTW PTA Scoring Balloon Catheter 2092-5040The Spectranetics Corporation · Catheter, Percutaneous, Cutting/Scoring28 reports
- 2cm Peripheral Cutting Balloon® M001PCB8020900Boston Scientific Corporation · Catheter, percutaneous, cutting/scoring18 reports
- AngioSculpt OTW PTA Scoring Balloon Catheter 2076-6040The Spectranetics Corporation · Catheter, Percutaneous, Cutting/Scoring17 reports
- AngioSculpt OTW PTA Scoring Balloon Catheter 2105-6040The Spectranetics Corporation · Catheter, Percutaneous, Cutting/Scoring17 reports
- ULTRASCORE US14150530Bard Peripheral Vascular, Inc. · Catheter, percutaneous, cutting/scoring15 reports
- ULTRASCORE US14150615Bard Peripheral Vascular, Inc. · Catheter, percutaneous, cutting/scoring14 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page